Pioneers in Heart Transplantation

The Stanford Heart Transplant Program has the accumulated wisdom of more than fifty years of research and patient care experience.

Our doctors and scientists work, collaboratively, to develop many innovations and continue to advance new techniques in transplant surgery.

Heart Failure and Cardiomyopathy Clinic at Boswell
300 Pasteur Drive
Stanford, CA 94305
Phone: 650-723-5468 Getting Here
Maps & Directions
300 Pasteur Drive
Stanford, CA 94305
Phone: 650-723-5468 Getting Here

Our Doctors

Care and Treatment

Translating Medical Advances into Patient Care

Stanford Hospital's physicians are faculty members at the Stanford School of Medicine, where they are at the forefront of the research that leads to ground-breaking treatments for patients. Stanford clinicians are scientists who regularly contribute to major advancements in their fields. The following research papers have been published by members of Stanford's Heart Transplant Team.

Clinical research studies

Clinical research studies are designed to answer specific questions, sometimes about a new drug or medical device's safety and effectiveness. Research studies may be observational studies or clinical trials. Observational studies are those in which information is collected from patients in order to better understand specific conditions (for example, what factors are associated with long-term survival after a heart transplant?) or to develop new tests that can detect rejection or other heart transplant complications in their early stages. Clinical trials are research studies in which patients are assigned, by chance, to a new medication or to placebo (typically a pill or liquid that looks like the study medication but does not have any medicines in it). Clinical trials are done to determine if new treatments are safe and effective in preventing or treating heart transplant complications.

Clinical research studies are done in close collaboration with scientists and physicians from many areas of expertise across Stanford University. To ensure the highest ethical standards are maintained, the Institutional Review Board (IRB) is responsible for oversight of all studies. You can find information about current clinical trials on the Stanford University Clinical Trial Directory site or at

Below are clinical research studies specifically related to heart transplantation that are currently being conducted at Stanford. Please be aware that studies often have extensive criteria that must be met before enrollment, and you may not be eligible for a given study.

Please feel free to discuss these studies with any member of the Heart Transplant team or contact the Heart Transplant Research Nurse Coordinator, Helen Luikart, RN, MS, at 650-724-2883.

Clinical and genetic evaluation of donors for cardiac transplantation (GED)

Funded by the National Institutes of Health, this is an observational study examining the relationship between donor characteristics and recipient outcomes after heart transplantation. We hope to learn whether clinical and genetic features of a heart transplant donor have an effect on outcomes after transplantation, including graft (donor heart) function, development of rejection, and survival. This study is open to adult heart transplant recipients during the first year after transplantation.

Determinants of long term survival

Funded by a grant from the Stiftung Charite Foundation, a non-profit in Germany, participants of this observational study will be enrolled at Stanford as well as at a collaborating site, the German Heart Institute in Berlin.  We hope to learn about distinguishing features of patients who survived for an extended period after heart transplantation.   This research study is open to those who received heart transplants at Stanford Hospital, and who have survived more than fifteen years after the transplant surgery.

Cardiac magnetic resonance imaging as a non-invasive tool for diagnosis of complications after heart transplantation

Funded by investigator funds, the purpose of this observational study is to provide comprehensive Cardiac MRI evaluation of heart transplant recipients. Participants will be followed for approximately one year to determine whether CMR findings predict future cardiovascular events.  The study is open to all heart transplant recipients who are able to undergo cardiac MRI. If you have any questions about this study, please contact Marie-Claude Parent, MD; or Phillip Yang, MD. Contact phone number:  650-714-3272 or 650-498-8008.

Heartware ventricular assist system continued access protocol

Funded by HeartWare, Inc., this is a continuation of a clinical trial involving the HeartWare Ventricular Assist System which was performed at 30 centers. The purpose of this study is to evaluate the safety and effectiveness of the HeartWare ventricular assist system in patients listed for heart transplant who have refractory, advanced heart failure and who are at risk of death. The original trial concluded in August 2010, but patients are still able to undergo implantation of the HeartWare ventricular assist system under a Continued Access Protocol approved by the U.S. Food and Drug Administration. Participants in this study are followed closely until they receive their heart transplant and then annually for five years. If you have questions about this study, please contact the Principal Investigators Philip Oyer, MD or Hari Mallidi, MD at 650-723-5771.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

For Patients

Your doctor may request an evaluation by a heart failure specialist, who will review your medical records and determine if additional tests are necessary.

Patients being considered for a heart transplant will be referred to the Cardiomyopathy Center. 

Self-referrals are accepted.


Bring results from prior lab tests, if requested.


Reach a transplant nurse coordinator at 650-498-9909.

International Patients
Phone: +1 650-723-8561

Call us to make an appointment